Found: 1
Select item for more details and to access through your institution.
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
- Published in:
- Diabetic Medicine, 2000, v. 17, n. 1, p. 40, doi. 10.1046/j.1464-5491.2000.00224.x
- By:
- Publication type:
- Article